WAUKEGAN, Ill.--(BUSINESS WIRE)--NEOPHARM, Inc. (NASDAQ:NEOL) presented its updated development projections for its drug candidates pipeline at its Annual Shareholder Meeting. A copy of the Company’s presentation can be found in its most recent 8-K filing.
